0001627187-16-000002.txt : 20160317 0001627187-16-000002.hdr.sgml : 20160317 20160317093601 ACCESSION NUMBER: 0001627187-16-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160317 DATE AS OF CHANGE: 20160317 EFFECTIVENESS DATE: 20160317 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Potenza Therapeutics, Inc. CENTRAL INDEX KEY: 0001627187 IRS NUMBER: 465416991 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-229558 FILM NUMBER: 161511396 BUSINESS ADDRESS: STREET 1: 1030 MASSSACHUSETTS AVENUE STREET 2: SUITE 210 CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: 617-588-4150 MAIL ADDRESS: STREET 1: 1030 MASSSACHUSETTS AVENUE STREET 2: SUITE 210 CITY: CAMBRIDGE STATE: MA ZIP: 02138 D/A 1 primary_doc.xml X0707 D/A LIVE 0001627187 Potenza Therapeutics, Inc. 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 617-588-4150 DELAWARE None None Corporation true 2013 Daniel Hicklin 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Executive Officer Director David Cordo 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Executive Officer Cynthia Seidel-Dugan 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Executive Officer Reid Leonard 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Executive Officer Luke Evnin 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Sakae Asanuma 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Arnold Oronsky 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Pharmaceuticals Decline to Disclose 06b true 0001627187-14-000001 2014-12-02 true true true false 0 38000000 30000000 8000000 false 6 0 0 0 false Potenza Therapeutics, Inc. /s/ Daniel Hicklin Daniel Hicklin President and Chief Executive Officer 2016-03-17